Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Liew

Showing results (371-380 of 481) with videos related to

Pageof 49
Sort By:
International Journal of Cardiology. Heart & Vasculature|July 19, 2021
Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblastsRuth R Magaye, Feby Savira, Xin Xiong, et al.
The American Journal of Cardiology|September 18, 2020
Relation of Timing of Percutaneous Coronary Intervention on Outcomes in Patients With Non-ST Segment Elevation Myocardial InfarctionRiley J Batchelor, Diem Dinh, Angela Brennan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 3, 2024
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetesElla Zomer, Jennifer Zhou, Adam J Nelson, et al.
Cardiovascular Drugs and Therapy|January 20, 2018
Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group RegistryKen Lee Chin, Rory Wolfe, Christopher M Reid, et al.
International Journal of Cardiology. Heart & Vasculature|July 8, 2021
Sex differences in Cardiac electronic device implantation: Outcomes from an Australian multi-centre clinical quality registryDavid Eccleston, Daniel Cehic, Glenn Young, et al.
British Journal of Pharmacology|April 7, 2020
Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculatureFeby Savira, Ruth Magaye, Danny Liew, et al.
Journal of Clinical Medicine|October 14, 2020
Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary InterventionSinjini Biswas, Diem Dinh, Mark Lucas, et al.
Pharmacoeconomics|September 4, 2017
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and ExtrapolationEddie Gibson, Ian Koblbauer, Najida Begum, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patientsPrudence A Russell, Stephen A Barnett, Marzena Walkiewicz, et al.
International Wound Journal|April 23, 2014
The cost-benefit of using soft silicone multilayered foam dressings to prevent sacral and heel pressure ulcers in trauma and critically ill patients: a within-trial analysis of the Border TrialNick Santamaria, Wei Liu, Marie Gerdtz, et al.
Pageof 49

Showing results (371-380 of 481) with videos related to

Sort By:
Pageof 49
International Journal of Cardiology. Heart & Vasculature|July 19, 2021
Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblastsRuth R Magaye, Feby Savira, Xin Xiong, et al.
The American Journal of Cardiology|September 18, 2020
Relation of Timing of Percutaneous Coronary Intervention on Outcomes in Patients With Non-ST Segment Elevation Myocardial InfarctionRiley J Batchelor, Diem Dinh, Angela Brennan, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 3, 2024
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetesElla Zomer, Jennifer Zhou, Adam J Nelson, et al.
Cardiovascular Drugs and Therapy|January 20, 2018
Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group RegistryKen Lee Chin, Rory Wolfe, Christopher M Reid, et al.
International Journal of Cardiology. Heart & Vasculature|July 8, 2021
Sex differences in Cardiac electronic device implantation: Outcomes from an Australian multi-centre clinical quality registryDavid Eccleston, Daniel Cehic, Glenn Young, et al.
British Journal of Pharmacology|April 7, 2020
Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculatureFeby Savira, Ruth Magaye, Danny Liew, et al.
Journal of Clinical Medicine|October 14, 2020
Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary InterventionSinjini Biswas, Diem Dinh, Mark Lucas, et al.
Pharmacoeconomics|September 4, 2017
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and ExtrapolationEddie Gibson, Ian Koblbauer, Najida Begum, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patientsPrudence A Russell, Stephen A Barnett, Marzena Walkiewicz, et al.
International Wound Journal|April 23, 2014
The cost-benefit of using soft silicone multilayered foam dressings to prevent sacral and heel pressure ulcers in trauma and critically ill patients: a within-trial analysis of the Border TrialNick Santamaria, Wei Liu, Marie Gerdtz, et al.
Pageof 49